Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Hypertension | Research

Obesity-and lipid-related indices as a risk factor of hypertension in mid-aged and elderly Chinese: a cross-sectional study

Authors: Jiaofeng Gui, Yuqing Li, Haiyang Liu, Lei-lei Guo, Jinlong Li, Yunxiao Lei, Xiaoping Li, Lu Sun, Liu Yang, Ting Yuan, Congzhi Wang, Dongmei Zhang, Jing Li, Mingming Liu, Ying Hua, Lin Zhang

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Objective

Hypertension refers to the persistent elevation of blood pressure above the established normal range, resulting in increased pressure exerted by blood on the walls of blood vessels during its circulation. Recent studies have identified significant associations between obesity and lipid-related indices, as well as hypertension. Nevertheless, these studies have yet to comprehensively examine the correlation between the two variables. Our objective is to identify the fat and lipid-related indices that have the strongest correlation with hypertension.

Method

There was a total of 9488 elderly and middle-aged Chinese citizens who participated in this investigation. The participants in this research were separated into distinct gender cohorts. The participants were classified into normal and hypertensive categories according to their gender, with hypertension defined as a blood pressure level of 140/90 mmHg or higher, or a history of hypertension. Through the utilization of binary logistic regression analyses and the receiver operator curve (ROC), the optimal among fourteen indicators associated with obesity and lipids were identified.

Results

After adjusting for variables, statistical analysis showed that all 14 measures of obesity and lipid were risk factors for hypertension. The receiver operating characteristic (ROC) curve analysis reveals that the Chinese visceral adiposity index (CVAI) has the highest degree of relationship to hypertension. Simultaneously, a statistically significant association between hypertension and these 14 variables was observed in both males and females.

Conclusion

There was a significant independent association between various parameters related to obesity and lipid-related index and the presence of hypertension, indicating that these factors can be considered risk factors for hypertension. CVAI and WHtR (waist height ratio) can be used to screen the high-risk groups of hypertensions in middle-aged and elderly people in China, and then take individualized health care measures to reduce the harm of hypertension.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liu LS. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.PubMed Liu LS. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.PubMed
2.
go back to reference Wang Z, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–56.PubMedCrossRef Wang Z, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–56.PubMedCrossRef
3.
go back to reference Oliveros E, et al. Hypertension in older adults: assessment, management, and challenges. Clin Cardiol. 2020;43(2):99–107.PubMedCrossRef Oliveros E, et al. Hypertension in older adults: assessment, management, and challenges. Clin Cardiol. 2020;43(2):99–107.PubMedCrossRef
4.
go back to reference Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94.CrossRef Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923–94.CrossRef
5.
go back to reference Li J, et al. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese Adults from 1993 to 2011. Int J Equity Health. 2017;16(1):50.PubMedPubMedCentralCrossRef Li J, et al. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese Adults from 1993 to 2011. Int J Equity Health. 2017;16(1):50.PubMedPubMedCentralCrossRef
7.
go back to reference Wang Q, et al. Rural-urban difference in blood pressure measurement frequency among elderly with hypertension: a cross-sectional study in Shandong, China. J Health Popul Nutr. 2018;37(1):25.PubMedPubMedCentralCrossRef Wang Q, et al. Rural-urban difference in blood pressure measurement frequency among elderly with hypertension: a cross-sectional study in Shandong, China. J Health Popul Nutr. 2018;37(1):25.PubMedPubMedCentralCrossRef
8.
go back to reference Ding L, et al. Smoking, heavy drinking, physical inactivity, and obesity among middle-aged and older adults in China: cross-sectional findings from the baseline survey of CHARLS 2011–2012. BMC Public Health. 2020;20(1):1062.PubMedPubMedCentralCrossRef Ding L, et al. Smoking, heavy drinking, physical inactivity, and obesity among middle-aged and older adults in China: cross-sectional findings from the baseline survey of CHARLS 2011–2012. BMC Public Health. 2020;20(1):1062.PubMedPubMedCentralCrossRef
11.
go back to reference da Silva AA, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82.PubMedCrossRef da Silva AA, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82.PubMedCrossRef
12.
go back to reference Masuo K, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42(4):474–80.PubMedCrossRef Masuo K, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42(4):474–80.PubMedCrossRef
13.
go back to reference Saito Y, et al. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–7.PubMedCrossRef Saito Y, et al. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–7.PubMedCrossRef
14.
15.
go back to reference Lin YP, et al. Insulin resistance indices and carotid intima-media thickness in physically fit adults: CHIEF atherosclerosis study. Endocr Metab Immune Disord Drug Targets. 2023;23(11):1442–8.PubMedCrossRef Lin YP, et al. Insulin resistance indices and carotid intima-media thickness in physically fit adults: CHIEF atherosclerosis study. Endocr Metab Immune Disord Drug Targets. 2023;23(11):1442–8.PubMedCrossRef
16.
go back to reference Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.PubMedCrossRef Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.PubMedCrossRef
17.
go back to reference Liu LS, Wu ZS, Wang JG, et al. 2018 Chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241. Liu LS, Wu ZS, Wang JG, et al. 2018 Chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241.
18.
go back to reference Zhang L, et al. Mediator or moderator? The role of obesity in the association between age at menarche and blood pressure in middle-aged and elderly Chinese: a population-based cross-sectional study. BMJ Open. 2022;12(5):e051486.PubMedPubMedCentralCrossRef Zhang L, et al. Mediator or moderator? The role of obesity in the association between age at menarche and blood pressure in middle-aged and elderly Chinese: a population-based cross-sectional study. BMJ Open. 2022;12(5):e051486.PubMedPubMedCentralCrossRef
20.
go back to reference Qian JD, et al. Comparative analysis of the association between traditional and lipid-related obesity indicators and isolated systolic hypertension: association of obesity indicators with ISH. BMC Cardiovasc Disord. 2022;22(1):119.PubMedPubMedCentralCrossRef Qian JD, et al. Comparative analysis of the association between traditional and lipid-related obesity indicators and isolated systolic hypertension: association of obesity indicators with ISH. BMC Cardiovasc Disord. 2022;22(1):119.PubMedPubMedCentralCrossRef
21.
go back to reference Vicente-Herrero MT, et al. Visceral adiposity index (VAI) and dysfunctional adiposity index (DAI). Relationship with obesity parameters. Semergen. 2023;49(6):101965.PubMedCrossRef Vicente-Herrero MT, et al. Visceral adiposity index (VAI) and dysfunctional adiposity index (DAI). Relationship with obesity parameters. Semergen. 2023;49(6):101965.PubMedCrossRef
22.
go back to reference Calderón-García JF, et al. Effectiveness of Body Roundness Index (BRI) and a Body Shape Index (ABSI) in predicting hypertension: a systematic review and meta-analysis of observational studies. Int J Environ Res Public Health. 2021;18(21):11607.PubMedPubMedCentralCrossRef Calderón-García JF, et al. Effectiveness of Body Roundness Index (BRI) and a Body Shape Index (ABSI) in predicting hypertension: a systematic review and meta-analysis of observational studies. Int J Environ Res Public Health. 2021;18(21):11607.PubMedPubMedCentralCrossRef
23.
go back to reference Gao W, et al. The association between the body roundness index and the risk of colorectal cancer: a cross-sectional study. Lipids Health Dis. 2023;22(1):53.PubMedPubMedCentralCrossRef Gao W, et al. The association between the body roundness index and the risk of colorectal cancer: a cross-sectional study. Lipids Health Dis. 2023;22(1):53.PubMedPubMedCentralCrossRef
24.
go back to reference Li H, et al. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Front Endocrinol (Lausanne). 2022;13:977625.PubMedCrossRef Li H, et al. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Front Endocrinol (Lausanne). 2022;13:977625.PubMedCrossRef
25.
26.
go back to reference Chen X, et al. Associations between abdominal obesity indices and nonalcoholic fatty liver disease: Chinese visceral adiposity index. Front Endocrinol (Lausanne). 2022;13:831960.PubMedCrossRef Chen X, et al. Associations between abdominal obesity indices and nonalcoholic fatty liver disease: Chinese visceral adiposity index. Front Endocrinol (Lausanne). 2022;13:831960.PubMedCrossRef
27.
go back to reference Li H, et al. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):105.PubMedPubMedCentralCrossRef Li H, et al. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):105.PubMedPubMedCentralCrossRef
28.
go back to reference Selvi NMK, et al. Association of triglyceride-glucose index (TyG index) with HbA1c and insulin resistance in type 2 diabetes mellitus. Maedica (Bucur). 2021;16(3):375–81.PubMed Selvi NMK, et al. Association of triglyceride-glucose index (TyG index) with HbA1c and insulin resistance in type 2 diabetes mellitus. Maedica (Bucur). 2021;16(3):375–81.PubMed
30.
go back to reference Bello-Chavolla OY, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44.PubMedCrossRef Bello-Chavolla OY, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44.PubMedCrossRef
31.
go back to reference Ji M, Zhang S, An R. Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis. Obes Rev. 2018;19(5):737–59.PubMedCrossRef Ji M, Zhang S, An R. Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis. Obes Rev. 2018;19(5):737–59.PubMedCrossRef
32.
go back to reference Fiorentino TV. Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives. Intern Emerg Med. 2018;13(4):471–3.PubMedCrossRef Fiorentino TV. Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives. Intern Emerg Med. 2018;13(4):471–3.PubMedCrossRef
33.
go back to reference Zhang Z, et al. Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives. Intern Emerg Med. 2018;13(4):509–16.PubMedCrossRef Zhang Z, et al. Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives. Intern Emerg Med. 2018;13(4):509–16.PubMedCrossRef
35.
go back to reference Han M, et al. Chinese visceral adiposity index, a novel indicator of visceral obesity for assessing the risk of incident hypertension in a prospective cohort study. Br J Nutr. 2021;126(4):612–20.PubMedCrossRef Han M, et al. Chinese visceral adiposity index, a novel indicator of visceral obesity for assessing the risk of incident hypertension in a prospective cohort study. Br J Nutr. 2021;126(4):612–20.PubMedCrossRef
36.
go back to reference Lin M, et al. Chinese visceral adiposity index is associated with incident renal damage in patients with hypertension and abnormal glucose metabolism: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:910329.PubMedCrossRef Lin M, et al. Chinese visceral adiposity index is associated with incident renal damage in patients with hypertension and abnormal glucose metabolism: a longitudinal study. Front Endocrinol (Lausanne). 2022;13:910329.PubMedCrossRef
37.
go back to reference Lee JW, et al. Anthropometric indices as predictors of hypertension among men and women aged 40–69 years in the Korean population: the Korean Genome and Epidemiology Study. BMC Public Health. 2015;15:140.PubMedPubMedCentralCrossRef Lee JW, et al. Anthropometric indices as predictors of hypertension among men and women aged 40–69 years in the Korean population: the Korean Genome and Epidemiology Study. BMC Public Health. 2015;15:140.PubMedPubMedCentralCrossRef
38.
go back to reference Wang Q, et al. Anthropometric indices predict the development of hypertension in normotensive and pre-hypertensive middle-aged women in Tianjin, China: a prospective cohort study. Med Sci Monit. 2018;24:1871–9.PubMedPubMedCentralCrossRef Wang Q, et al. Anthropometric indices predict the development of hypertension in normotensive and pre-hypertensive middle-aged women in Tianjin, China: a prospective cohort study. Med Sci Monit. 2018;24:1871–9.PubMedPubMedCentralCrossRef
39.
go back to reference Wang K, et al. Association of triglyceride-glucose index and its interaction with obesity on hypertension risk in Chinese: a population-based study. J Hum Hypertens. 2021;35(3):232–9.PubMedCrossRef Wang K, et al. Association of triglyceride-glucose index and its interaction with obesity on hypertension risk in Chinese: a population-based study. J Hum Hypertens. 2021;35(3):232–9.PubMedCrossRef
40.
go back to reference Mao Y, et al. Association of three insulin resistance indices with hypertension and body weight among Uyghur adults in rural areas of Xinjiang, China. J Clin Hypertens (Greenwich). 2022;24(11):1498–505.PubMedCrossRef Mao Y, et al. Association of three insulin resistance indices with hypertension and body weight among Uyghur adults in rural areas of Xinjiang, China. J Clin Hypertens (Greenwich). 2022;24(11):1498–505.PubMedCrossRef
41.
go back to reference Chang Y, et al. The feasibility of two new anthropometric indices to identify hypertension in rural China: a cross-sectional study. Medicine (Baltimore). 2016;95(44):e5301.PubMedCrossRef Chang Y, et al. The feasibility of two new anthropometric indices to identify hypertension in rural China: a cross-sectional study. Medicine (Baltimore). 2016;95(44):e5301.PubMedCrossRef
42.
go back to reference Li Y, et al. Body roundness index and waist-hip ratio result in better cardiovascular disease risk stratification: results from a large Chinese cross-sectional study. Front Nutr. 2022;9:801582.PubMedPubMedCentralCrossRef Li Y, et al. Body roundness index and waist-hip ratio result in better cardiovascular disease risk stratification: results from a large Chinese cross-sectional study. Front Nutr. 2022;9:801582.PubMedPubMedCentralCrossRef
45.
go back to reference Jordan J, et al. Natriuretic peptides in cardiovascular and metabolic crosstalk: implications for hypertension management. Hypertension. 2018;72(2):270–6.PubMedCrossRef Jordan J, et al. Natriuretic peptides in cardiovascular and metabolic crosstalk: implications for hypertension management. Hypertension. 2018;72(2):270–6.PubMedCrossRef
Metadata
Title
Obesity-and lipid-related indices as a risk factor of hypertension in mid-aged and elderly Chinese: a cross-sectional study
Authors
Jiaofeng Gui
Yuqing Li
Haiyang Liu
Lei-lei Guo
Jinlong Li
Yunxiao Lei
Xiaoping Li
Lu Sun
Liu Yang
Ting Yuan
Congzhi Wang
Dongmei Zhang
Jing Li
Mingming Liu
Ying Hua
Lin Zhang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04650-2

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine